Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Silence Therapeutics PLC 05 August 2021 Additional listing and Total Voting Rights 5 August 2021 LONDON, Silence Therapeutics plc, AIM:SLN and...
Silence Therapeutics PLC 15 July 2021 Silence Therapeutics Notice of Half Year Results 15 July 2021 LONDON, Silence Therapeutics plc , AIM: SLN...
Silence Therapeutics PLC 15 June 2021 Results of Annual General Meeting 15 June 2021 LONDON, Silence Therapeutics plc, AIM:SLN and Nasdaq: SLN...
Silence Therapeutics PLC 07 June 2021 Silence Therapeutics to Present Data Highlighting Broad Therapeutic Potential for SLN124 at the European...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
Silence Therapeutics PLC 25 May 2021 Silence Therapeutics Receives Remaining $40 Million from AstraZeneca as Part of Upfront Investment for...
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...
Silence Therapeutics PLC 19 May 2021 Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Volunteers - Data...
Silence Therapeutics PLC 12 May 2021 Silence Therapeutics to Participate in Fireside Chat at the RBC Capital Markets Global Healthcare Conference...
Silence Therapeutics PLC 07 May 2021 Notice of Annual General Meeting 7 May 2021 LONDON, Silence Therapeutics plc, AIM:SLN and Nasdaq: SLN...
Silence Therapeutics PLC 30 April 2021 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
Silence Therapeutics PLC 29 April 2021 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
Silence Therapeutics PLC 29 April 2021 Silence Therapeutics Announces First Patient Dosed in GEMINI II Phase I Clinical Trial for SLN124 - First...
ics PLC - novel RNA therapeutics developer with offices in London and Berlin - Achieves further research milestone as ...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관